Nitric oxide synthase activity is up-regulated in melanoma cell lines: A potential mechanism for metastases formation

Melanoma Research

Volumn 6, Issue 2, 1996, Pages 121-126

  Joshi, M ^a   Strandhoy, J ^a   White, W L ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

melanocytes; melanoma cells; metastasis; nitric oxide synthase

Indexed keywords

N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR;

ARTICLE; CONTROLLED STUDY; CYTOLYSIS; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MELANOCYTE; MELANOMA; MELANOMA CELL; METASTASIS; PRIORITY JOURNAL; TUMOR BLOOD FLOW; VASODILATATION;

EID: 0029782487     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-199604000-00006     Document Type: Article

References (17)

1. Folkman J. How is blood vessel growth regulated in normal and neoplastic tissue? G. H. A. Clowes memorial Award lecture. Cancer Res 1986; 46: 467-473.
2. Denijn M, Ruiter DJ. The possible role of angiogenesis in the metastatic potential of human melanoma. Clinicopathological aspects Melanoma Res 1993; 3: 5-14.
3. Miller FR, Heppner GH. Cellular interactions in metastasis. Cancer Metastasis Rev 1990, 9: 21-34.
4. Polverini PJ, Cotran RS, Gimbrone MA, et al. Activated macrophages induce vascular proliferation. Nature 1977; 269: 804-806.
5. Rastinejad F, Polverini PJ, Bouck NP. Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene. Cell 1989; 56: 345-355.
6. Folkman J, Watson K, Ingbar D, et al. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 1989; 339: 58-61.
7. Yang WJ, Korenaga R, et al. Exogenous nitric oxide inhibits proliferation of cultured vascular endothelial cells. Biochem Biophys Res Commun 1994; 203: 1160-1167.
8. Marx A, Kuklinska E, Molellmann G, et al. Nitric oxide in cultured human melanocytes. Pigment Cell Res 1994; Suppl. 3: 24.
9. Halaban R, Rubin J, Funasaka Y, et al. Met and hepatocyte growth factor/scatter factor signal transduction in normal melanocytes and melanoma cells. Oncogene 1992; 7: 2195-2206.
10. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254.
11. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathology and pharmacology. Pharmacol Rev 1991; 43: 109-142.
12. Langrehr JM, Hoffman RA, Lancaster JR, et al. Nitric oxide - a new endogenous immunomodulator. Transplantation 1993; 55: 1205-1212.
13. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J 1992; 6: 3051-3064.
14. Folkman J. Anti-angiogenesis: new concept for therapy of solid tumors. Ann Surg 1972; 175: 409-416.
15. Graham CH, Rivers J, Kerbel RS, et al. Extent of vascularization as a prognistic indicator in thin ( <0.76 mm) malignant melanomas. Am J Pathol 1994; 145: 510-514.
16. Barnhill RL, Busam KL, Berwick M, et al. Tumour vascularity is not a prognostic factor for cutaneous melanoma (letter). Lancet 1994; 344: 1237-1238.
17. Dong Z, Staroselsky AH. Qi X, et al. Inverse correlation between expression of inducible nitric oxide synthase activity and production of metastasis in K-1735 murine melanoma cells. Cancer Res 1994; 54: 789-793.